Biomx Inc logo

PHGE - Biomx Inc Share Price

$7.94 0.7  9.2%

Last Trade - 24/02/21

Sector
Healthcare
Size
Small Cap
Market Cap £221.5m
Enterprise Value £176.4m
Revenue £n/a
Position in Universe 3991st / 6714
Bullish
Bearish
Unlock PHGE Revenue
Momentum
Relative Strength (%)
1m +11.1%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -31.7%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2020, BiomxInc revenues was not reported. Net loss increased from$282K to $20.9M. Higher net loss reflects Research anddevelopment (R& increase from $0K to $13.1M (expense).Basic Earnings per Share excluding Extraordinary Itemsdecreased from -$0.13 to -$0.91.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

PHGE Revenue Unlock PHGE Revenue

Net Income

PHGE Net Income Unlock PHGE Revenue

Normalised EPS

PHGE Normalised EPS Unlock PHGE Revenue

PE Ratio Range

PHGE PE Ratio Range Unlock PHGE Revenue

Dividend Yield Range

PHGE Dividend Yield Range Unlock PHGE Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
PHGE EPS Forecasts Unlock PHGE Revenue
Profile Summary

BiomX Inc., formerly Chardan Healthcare Acquisition Corp., is a microbiome company. The Company is focused on developing both natural and engineered phage therapies. It develops therapies to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC) and cancer. The Company discovers and validates bacterial targets and customizes phage compositions against the targets. Its pipeline includes BX001, BX002 and BX003. BX001 is a product candidate that improves the appearance of acne-prone skin. BX002 is a customized phage cocktail that eradicates bacterial targets associated with the onset of IBD. BX003 is a customized phage cocktail developed against specific strains of Klebsiella pneumoniae (Kp).

Directors
Last Annual December 31st, 2019
Last Interim September 30th, 2020
Incorporated November 1, 2017
Public Since December 14, 2018
No. of Shareholders: n/a
No. of Employees: 73
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange NYSE MKT
Shares in Issue 23,177,922
Free Float (0.0%)
Eligible for
ISAs
SIPPs
PHGE Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for PHGE
Upcoming Events for PHGE
Frequently Asked Questions for Biomx Inc
What is the Biomx Inc share price?

As of 24/02/21, shares in Biomx Inc are trading at $7.94, giving the company a market capitalisation of £221.5m. This share price information is delayed by 15 minutes.

How has the Biomx Inc share price performed this year?

Shares in Biomx Inc are currently trading at $7.94 and the price has moved by -23.19% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Biomx Inc price has moved by -38.02% over the past year.

What are the analyst and broker recommendations for Biomx Inc?

There are no analysts currently covering Biomx Inc.

When will Biomx Inc next release its financial results?

Biomx Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the Biomx Inc dividend yield?

Biomx Inc does not currently pay a dividend.

Does Biomx Inc pay a dividend?

Biomx Inc does not currently pay a dividend.

When does Biomx Inc next pay dividends?

Biomx Inc does not currently pay a dividend.

How do I buy Biomx Inc shares?

To buy shares in Biomx Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Biomx Inc?

Shares in Biomx Inc are currently trading at $7.94, giving the company a market capitalisation of £221.5m.

Where are Biomx Inc shares listed? Where are Biomx Inc shares listed?

Here are the trading details for Biomx Inc:

Country of listing: United States
Exchange: ASQ
Ticker Symbol: PHGE
What kind of share is Biomx Inc?

Based on an overall assessment of its quality, value and momentum, Biomx Inc is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Biomx Inc share price forecast 2021?

Shares in Biomx Inc are currently priced at $7.94. At that level they are trading at 0.207% discount to the analyst consensus target price of 0.00.

Analysts covering Biomx Inc currently have a consensus Earnings Per Share (EPS) forecast of -1.263 for the next financial year.

How can I tell whether the Biomx Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biomx Inc. Over the past six months, the relative strength of its shares against the market has been 8.03%. At the current price of $7.94, shares in Biomx Inc are trading at 18.49% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Biomx Inc PE Ratio?

We were not able to find PE ratio data for Biomx Inc.

Who are the key directors of Biomx Inc?

Biomx Inc's management team is headed by:

Gbola Amusa - IND
Jonas Grossman - IND
Russell Greig - CHM
Jonathan Solomon - CEO
Lynne Sullivan - IND
Marina Wolfson - CFO
Assaf Oron - OTH
Sailaja Puttagunta - OTH
Merav Bassan - OTH
Alan Moses - IND
Paul Sekhri - IND
Who are the major shareholders of Biomx Inc?

Here are the top five shareholders of Biomx Inc based on the size of their shareholding:

Takeda Pharmaceutical Co Ltd Corporation
Percentage owned: 10.66% (2.47m shares)
OrbiMed Advisors, LLC Investment Advisor/Hedge Fund
Percentage owned: 9.98% (2.31m shares)
Johnson & Johnson Innovation-JJDC, Inc. Venture Capital
Percentage owned: 9.2% (2.13m shares)
Chardan Investments LLC Corporation
Percentage owned: 7.37% (1.71m shares)
MMCAP Asset Management Hedge Fund
Percentage owned: 2.95% (684k shares)
Similar to PHGE
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.